-+ 0.00%
-+ 0.00%
-+ 0.00%

Candel Therapeutics grants new CCO Mark Sims options for 285,000 shares at $10.03 each

PUBT·07/08/2026 20:05:26
Listen to the news
Candel Therapeutics grants new CCO Mark Sims options for 285,000 shares at $10.03 each
  • Candel Therapeutics granted new Chief Commercial Officer Mark Sims stock options for 285,000 common shares as an employment inducement.
  • Options carry a USD 10.03 exercise price, matching the Nasdaq close on July 6, 2026.
  • Vesting: 25% on the first anniversary of Sims’ start date; remaining 75% in 36 equal monthly installments.
  • Award was issued under the company’s 2025 Inducement Plan, adopted Dec. 24, 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607081605PRIMZONEFULLFEED9758572) on July 08, 2026, and is solely responsible for the information contained therein.